Christophe P. Weber

    1 board
    Healthcare
    As of 8/31/2026

    0.21

    Boardminder Score™

    Bottom 8% of 4,262 directors

    Lower scoreHigher score

    0.6

    Avg Tenure (yrs)

    Shorter tenure than 99% of directors

    ShorterLonger

    Total Compensation

    Board Seats Breakdown
    Boston Scientific Corporation
    BSX
    F500 #217
    Chief Executive Officer, Takeda Pharmaceutical Company, Limited
    Healthcare
    Seat Score
    0.21
    Tenure
    0.6 yrs
    Compensation
    Excess Return
    -57.7%